Categories
HF51116

HF51116

HY-144347
2177311-29-2

MCE
MIF-IN-2

MIF-IN-2

HY-144194
2756410-57-6

$545.0 / 1mg

MCE
Daclizumab

Daclizumab

HY-108738
152923-56-3

MCE
CCR4 antagonist 2

CCR4 antagonist 2

HY-125836
2206788-99-8

MCE
MIF-IN-5

MIF-IN-5

HY-146318
2582755-31-3

MCE
Cibisatamab

Cibisatamab

HY-P99011
1855925-27-7

$680.0 / 1mg

MCE
Glofitamab

Glofitamab

HY-P99024
2229047-91-8

$580.0 / 1mg

MCE
Etokimab

Etokimab

HY-P99018
2022981-44-6

MCE
NRP1 antagonist 1

NRP1 antagonist 1

HY-133034
2569598-01-0

$121.0 / 10 mM * 1 mL in DMSO

MCE
Isoandrographolide

Isoandrographolide

HY-N10359
4176-96-9

$300.0 / 1mg

MCE
CXCR2 antagonist 4
Rafutrombopag (tautomerism)

Rafutrombopag (tautomerism)

HY-122620
2114365-78-3

$656.0 / 10 mM * 1 mL in DMSO

MCE
Foralumab

Foralumab

HY-P99199
946415-64-1

$260.0 / 1mg

MCE
Eldelumab

Eldelumab

HY-P99190
946414-98-8

$290.0 / 1mg

MCE
Cemiplimab

Cemiplimab

HY-P99203
1801342-60-8

MCE
Emapalumab

Emapalumab

HY-P99191
1709815-23-5

MCE
Carlumab

Carlumab

HY-P99188
915404-94-3

MCE
Fezakinumab

Fezakinumab

HY-P99244
1007106-86-6

MCE
Risankizumab

Risankizumab

HY-P99248
1612838-76-2

$295.0 / 1mg

MCE